We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Sanofi | NASDAQ:SNY | NASDAQ | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.37 | -2.73% | 48.73 | 48.72 | 48.74 | 48.80 | 48.10 | 48.19 | 754,549 | 20:01:15 |
From May 2023 to May 2024
By Will Feuer
MeiraGTx Holdings said it has received a $30 million investment from French pharmaceutical company Sanofi, and said the company has been approached by multiple parties about certain assets.
MeiraGTx, a clinical-stage gene-therapy company, said Sanofi bought 4 million shares at a price of $7.50 a share. Sanofi will receive a right of first negotiation for the use of MeiraGTx's Riboswitch gene-regulation technology for various uses, including in GLP-1 drugs.
The company said it is also actively pursuing options after multiple parties approached MeiraGTx with interest in some of the company's assets. MeiraGTx has hired Evercore as a financial advisor and Wachtell, Lipton, Rosen & Katz as legal advisor.
Write to Will Feuer at Will.Feuer@wsj.com
(END) Dow Jones Newswires
October 30, 2023 07:59 ET (11:59 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year Sanofi Chart |
1 Month Sanofi Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
